01—History
Free Cash Flow History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- −$967.6M
YoY changeLargest recent move−66.7%in FY18Latest −37.1%
1 older move runs past ±100% (largest −303.8%); point at, tap or drag across the bars to read one.
02—Ledger
Free Cash Flow, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | −$967.6M | −37.1% | 10-K | |
| FY2024 | −$705.8M | −28.4% | 10-K | |
| FY2023 | −$549.5M | −33.9% | 10-K | |
| FY2022 | −$410.3M | −10.7% | 10-K | |
| FY2021 | −$370.6M | −64.3% | 10-K | |
| FY2020 | −$225.6M | +23.0% | 10-K | |
| FY2019 | −$292.9M | −8.1% | 10-K | |
| FY2018 | −$271.1M | −66.7% | 10-K | |
| FY2017 | −$162.6M | −7.8% | 10-K | |
| FY2016 | −$150.9M | −44.9% | 10-K | |
| FY2015 | −$104.2M | −49.3% | 10-K | |
| FY2014 | −$69.8M | −46.9% | 10-K | |
| FY2013 | −$47.5M | −51.7% | 10-K | |
| FY2012 | −$31.3M | −0.4% | 10-K | |
| FY2011 | −$31.2M | −303.8% | 10-K | |
| FY2010 | −$7.7M | +29.9% | 10-K | |
| FY2009 | −$11.0M | — | 10-K |
03—Questions
What is Insmed's current free cash flow?
Insmed (INSM) annual free cash flow for 2025 was $-967.6M, a 37.09% decline from 2024. Insmed free cash flow for the quarter ending September 30, 2026 was $-42.1M.
What was Insmed's free cash flow in 2024?
Insmed annual free cash flow for 2024 was $-705.8M, a 28.44% decline from 2023.
What was Insmed's free cash flow in 2023?
Insmed annual free cash flow for 2023 was $-549.5M, a 33.93% decline from 2022.
- Company
- Insmed
- Ticker
- INSM
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations